Residency · Omaha, NE
Sponsored by University of Nebraska Medical Center College of Medicine
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Leukemia · 2022 · 3,530 citations · Joseph Khoury
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Leukemia · 2022 · 3,300 citations · Joseph Khoury
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Blood · 2022 · 1,363 citations · Julie Vose, Wing Chan
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
The New England journal of medicine · 2021 · 1,404 citations · Andre Kalil
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.
Lancet (London, England) · 2022 · 698 citations · Matthew Lunning
Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update.
Infection control and hospital epidemiology · 2022 · 319 citations · Mark Rupp
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 226 citations · Subodh Lele
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study.
Blood · 2023 · 369 citations · Matthew Lunning